Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRRT-miECCO<sub>2</sub>R: a step toward integrated multiorgan support.

Critical care (London, England)·2026
Same author

Implementation of the kidney protection strategy in critically ill patients with acute kidney injury - a multi-center prospective cohort study.

Critical care (London, England)·2026
Same author

Minimally invasive extracorporeal CO<sub>2</sub> removal in hypercapnic respiratory failure: a prospective observational study.

Critical care (London, England)·2026
Same author

Assessment of pulmonary function in a mouse model of bronchopulmonary dysplasia by unrestrained whole body plethysmography and the forced oscillation technique.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Case Report: Tezepelumab as rescue therapy in near-fatal asthma requiring extracorporeal membrane oxygenation.

Frontiers in immunology·2026
Same author

Genetic contribution to severe COVID-19 in adults under 60 years without major comorbidities in the German National Pandemic Cohort Network (NAPKON).

Human genomics·2026

Related Experiment Video

Updated: May 25, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
07:52

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

Hypercapnia: a nonpermissive environment for the lung.

István Vadász1, Rolf D Hubmayr, Nicolás Nin

  • 1Department of Internal Medicine, University of Giessen Lung Center, Justus Liebig University, Germany. istvan.vadasz@innere.med.uni-giessen.de

American Journal of Respiratory Cell and Molecular Biology
|January 17, 2012
PubMed
Summary

Elevated carbon dioxide (CO(2)), or hypercapnia, may harm lung function in patients with lung diseases. Recent research indicates CO(2) signaling can negatively impact lung barriers, fluid clearance, and immunity.

More Related Videos

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

Evaluation of Capnography Sampling Line Compatibility and Accuracy when Used with a Portable Capnography Monitor
07:51

Evaluation of Capnography Sampling Line Compatibility and Accuracy when Used with a Portable Capnography Monitor

Published on: September 29, 2020

Related Experiment Videos

Last Updated: May 25, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
07:52

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

Evaluation of Capnography Sampling Line Compatibility and Accuracy when Used with a Portable Capnography Monitor
07:51

Evaluation of Capnography Sampling Line Compatibility and Accuracy when Used with a Portable Capnography Monitor

Published on: September 29, 2020

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology
  • Cellular Signaling

Background:

  • Severe acute and chronic lung diseases cause gas exchange derangements, potentially leading to hypercapnia (elevated CO(2) levels).
  • The health effects of hypercapnia are not fully understood, with some proposing beneficial roles in acute lung injury ('permissive' or 'therapeutic' hypercapnia).
  • Emerging evidence suggests CO(2) acts as a pH-independent signaling molecule with potential adverse effects on the lung.

Purpose of the Study:

  • To review recent research on cellular sensing of elevated CO(2) in the lung.
  • To explore the potential harmful effects of hypercapnia on lung health.
  • To raise concerns regarding the implications of hypercapnia in patients with acute and chronic lung diseases.

Main Methods:

  • Literature review of recent research on CO(2) sensing and its effects in the lung.
  • Analysis of studies investigating hypercapnia's impact on epithelial and endothelial barriers.
  • Examination of research on hypercapnia's influence on lung edema clearance, innate immunity, and host defense.

Main Results:

  • CO(2) can be sensed by lung cells through pH-independent mechanisms.
  • Elevated CO(2) may exert deleterious effects on the epithelial and endothelial barriers.
  • Hypercapnia can potentially impair lung edema clearance, innate immunity, and host defense.

Conclusions:

  • Recent findings challenge the notion of universally beneficial hypercapnia in lung diseases.
  • CO(2) signaling may contribute to lung injury through various cellular and physiological pathways.
  • Concerns exist regarding the safety and potential harm of hypercapnia in patients with acute and chronic lung conditions.